About ALA Diagnostics
ALA Diagnostics is a company based in Madrid (Spain) founded in 2019 by Jose Ramon Montero.. ALA Diagnostics has raised $1.2 million across 1 funding round from investors including BeAble Capital. ALA Diagnostics offers products and services including EM KIT and In Vitro Diagnostic Kits. ALA Diagnostics operates in a competitive market with competitors including ADx NeuroSciences, Cytox, Amprion, PeopleBio R&D and Durin Technologies, among others.
- Headquarter Madrid, Spain
- Founders Jose Ramon Montero
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.2 M (USD)
in 1 rounds
-
Latest Funding Round
$1.2 M (USD), Seed
Jun 22, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ALA Diagnostics
ALA Diagnostics offers a comprehensive portfolio of products and services, including EM KIT and In Vitro Diagnostic Kits. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Kit for early blood-based diagnosis of Multiple Sclerosis.
Kits for diagnosing high-prevalence pathologies through sample analysis.
Funding Insights of ALA Diagnostics
ALA Diagnostics has successfully raised a total of $1.2M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.2 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.2M
-
First Round
First Round
(22 Jun 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Seed - ALA Diagnostics | Valuation | BeAble Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ALA Diagnostics
ALA Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include BeAble Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early stage energy and tech focused VC firm investing primarily in Spain
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ALA Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ALA Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ala Diagnostics Comparisons
Competitors of ALA Diagnostics
ALA Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ADx NeuroSciences, Cytox, Amprion, PeopleBio R&D and Durin Technologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biomarker assays for neurodegenerative diseases are developed using custom antibodies.
|
|
| domain | founded_year | HQ Location |
Prognostic tests for assessing dementia risk are developed.
|
|
| domain | founded_year | HQ Location |
Assay technology for misfolded proteins in neurodegenerative disorders is developed.
|
|
| domain | founded_year | HQ Location |
Immunoassays are developed for early detection of neurodegenerative diseases.
|
|
| domain | founded_year | HQ Location |
Developer of the diagnostic test for neurodegenerative diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ala Diagnostics
Frequently Asked Questions about ALA Diagnostics
When was ALA Diagnostics founded?
ALA Diagnostics was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Where is ALA Diagnostics located?
ALA Diagnostics is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Is ALA Diagnostics a funded company?
ALA Diagnostics is a funded company, having raised a total of $1.2M across 1 funding round to date. The company's 1st funding round was a Seed of $1.2M, raised on Jun 22, 2023.
What does ALA Diagnostics do?
ALA Diagnostics was founded in 2019 in Madrid, Spain, within the biotechnology sector. In vitro diagnostic kits for detecting multiple sclerosis are developed by the company. A blood test that utilizes a patented recombinant protein as a biomarker for multiple sclerosis is provided. Operations center on advancing diagnostic tools for neurological conditions, with a focus on accessible testing methods in Europe.
Who are the top competitors of ALA Diagnostics?
ALA Diagnostics's top competitors include Amprion, ADx NeuroSciences and PeopleBio R&D.
What products or services does ALA Diagnostics offer?
ALA Diagnostics offers EM KIT and In Vitro Diagnostic Kits.
Who are ALA Diagnostics's investors?
ALA Diagnostics has 1 investor. Key investors include BeAble Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.